Equities Research Analysts’ Upgrades for November 1st (AKBA, BETA, BWA, BXC, CAL, CBAN, CROX, CRSR, CSTL, HOS)

Equities Research Analysts’ upgrades for Sunday, November 1st:

Akebia Therapeutics (NASDAQ:AKBA) was upgraded by analysts at Wall Street Zen from a sell rating to a hold rating.

BETA Technologies (NYSE:BETA) was upgraded by analysts at Wall Street Zen from a sell rating to a hold rating.

BorgWarner (NYSE:BWA) was upgraded by analysts at Wall Street Zen from a hold rating to a buy rating.

BlueLinx (NYSE:BXC) was upgraded by analysts at Wall Street Zen from a hold rating to a buy rating.

Caleres (NYSE:CAL) was upgraded by analysts at Wall Street Zen from a buy rating to a strong-buy rating.

Colony Bankcorp (NYSE:CBAN) was upgraded by analysts at Wall Street Zen from a hold rating to a buy rating.

Crocs (NASDAQ:CROX) was upgraded by analysts at Wall Street Zen from a buy rating to a strong-buy rating.

Corsair Gaming (NASDAQ:CRSR) was upgraded by analysts at Wall Street Zen from a buy rating to a strong-buy rating.

Castle Biosciences (NASDAQ:CSTL) was upgraded by analysts at Wall Street Zen from a hold rating to a buy rating.

Hornbeck Offshore Services (NYSE:HOS) was upgraded by analysts at Wall Street Zen from a hold rating to a buy rating.

Hilltop (NYSE:HTH) was upgraded by analysts at Wall Street Zen from a strong sell rating to a sell rating.

Intellicheck (NASDAQ:IDN) was upgraded by analysts at Wall Street Zen from a hold rating to a buy rating.

Terrestrial Energy (NASDAQ:IMSR) was upgraded by analysts at Wall Street Zen from a strong sell rating to a sell rating.

Infleqtion (NYSE:INFQ) was upgraded by analysts at Wall Street Zen from a strong sell rating to a sell rating.

JAKKS Pacific (NASDAQ:JAKK) was upgraded by analysts at Wall Street Zen from a buy rating to a strong-buy rating.

Klarna Group (NYSE:KLAR) was upgraded by analysts at Wall Street Zen from a sell rating to a hold rating.

Lazard (NYSE:LAZ) was upgraded by analysts at Wall Street Zen from a sell rating to a hold rating.

Liberty Energy (NYSE:LBRT) was upgraded by analysts at Wall Street Zen from a strong sell rating to a sell rating.

L3Harris Technologies (NYSE:LHX) was upgraded by analysts at Wall Street Zen from a hold rating to a buy rating.

Mueller Industries (NYSE:MLI) was upgraded by analysts at Wall Street Zen from a hold rating to a buy rating.

monday.com (NASDAQ:MNDY) was upgraded by analysts at Wall Street Zen from a hold rating to a buy rating.

NewAmsterdam Pharma (NASDAQ:NAMS) was upgraded by analysts at Wall Street Zen from a sell rating to a hold rating.

ONE Gas (NYSE:OGS) was upgraded by analysts at Wall Street Zen from a sell rating to a hold rating.

Pharming Group (NASDAQ:PHAR) was upgraded by analysts at Wall Street Zen from a hold rating to a strong-buy rating.

Plexus (NASDAQ:PLXS) was upgraded by analysts at Wall Street Zen from a hold rating to a buy rating.

RenovoRx (NASDAQ:RNXT) was upgraded by analysts at Wall Street Zen from a sell rating to a hold rating.

Ross Stores (NASDAQ:ROST) was upgraded by analysts at Wall Street Zen from a hold rating to a buy rating.

SolarEdge Technologies (NASDAQ:SEDG) was upgraded by analysts at Wall Street Zen from a sell rating to a hold rating.

Sphere Entertainment (NYSE:SPHR) was upgraded by analysts at Wall Street Zen from a sell rating to a hold rating.

Stellantis (NYSE:STLA) was upgraded by analysts at Wall Street Zen from a strong sell rating to a hold rating.

Titan Machinery (NASDAQ:TITN) was upgraded by analysts at Wall Street Zen from a sell rating to a hold rating.

United Bankshares (NASDAQ:UBSI) was upgraded by analysts at Wall Street Zen from a sell rating to a hold rating.

Controladora Vuela Compania de Aviacion (NYSE:VLRS) was upgraded by analysts at Wall Street Zen from a sell rating to a hold rating.

West Pharmaceutical Services (NYSE:WST) was upgraded by analysts at Wall Street Zen from a hold rating to a buy rating.

Receive News & Ratings for Akebia Therapeutics Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Akebia Therapeutics Inc and related companies with MarketBeat.com's FREE daily email newsletter.